Navigation Links
Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
Date:11/1/2007

officer. "In addition, we have initiated a Phase 1 study with our second FLAP inhibitor, AM803, using a similar trial design to AM103. These are exciting times at Amira as our team continues to demonstrate world-class capabilities in drug discovery and development, particularly through the impressive progress of these two drug candidates."

Discussions are continuing with a number of potential pharmaceutical partners interested in Amira's FLAP program.

About FLAP Inhibitors

FLAP is a key component early in the leukotriene pathway, a complex signaling process that exerts control over biological processes, such as inflammation and immunity. Excessive activity of FLAP exacerbates inflammatory diseases, such as asthma; the FLAP gene has also been linked to a significant increase in the risk of myocardial infarction and stroke. AM103 binds to FLAP, inhibiting the synthesis of leukotrienes that cause inflammation.

A FLAP inhibitor is active at a point higher in the leukotriene pathway than a CysLT1 receptor antagonist, enabling it potentially to inhibit the production of all leukotrienes. Leukotrienes, prostaglandins and other arachidonic acid-derived lipids make up the eicosanoid family of inflammatory mediators.

About Amira

Founded in 2005 and headquartered in San Diego, Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of compounds to treat inflammatory disease linked to the eicosanoid pathway.

The company combines the rigor of a big pharmaceutical company with the ingenuity and energy of a small company, creating an environment for efficient and effective pre-clinical and clinical program decisions. Its scientific founders have successfully worked together for more than a decade and were pivotal in the discovery of a number of inflammatory drugs, including Singulair(R). The drug hunters at Amira are now actively leveraging their history of success to create high-valu
'/>"/>

SOURCE Amira Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Supply of Radiopharmaceuticals Hampered by Attacks
2. FDA approves Watson Pharmaceuticals Oxytrol patch
3. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
4. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
5. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
6. Top Pharmaceuticals Influence Doctors Prescriptions
7. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
8. Personalized Medicine and Innovative Pharmaceuticals
9. New lease of life for asthmatics by Accentia Biopharmaceuticals
10. Pravastatin Launched by Watson Pharmaceuticals
11. Tata Industries picks up stake in Indigene Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... August 28, 2015 , ... ... loyalty at a low cost. Personalized with practice contact information and logos, Calendars ... Dental offices can also incorporate Calendars into seasonal mailings, thank you and welcome ...
(Date:8/28/2015)... ... 2015 , ... SharkNinja, an innovative leader in the housewares ... Sofia Vergara, and unveil the Ninja® brand’s new coffee machine, the Ninja ... variety of sizes and styles while achieving the perfect brew richness level every ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... added comprehensive information on two new duals programs: Rhode Island Integrated Care ... and Idaho’s partnership to revamp Blue Cross of Idaho’s D-SNP. The database ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Plaintiffs ... as MDL 2545, Testosterone Replacement Therapy Products Liability Litigation, are in the midst ... custodial files the PSC may receive for corporate employees involved in the production ...
(Date:8/28/2015)... ... August 28, 2015 , ... Super-Sod launched their new website this ... most notable change is the responsive web design. Website users will now have an ... submit quote requests for sod, sign-up for the monthly turf-tips email, and find a ...
Breaking Medicine News(10 mins):Health News:SmartPractice® Introduces 2016 Calendars for Dental Practice Giveaways 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 3Health News:AIS Duals Database: August Update Finds Two New Duals Programs in Rhode Island and Idaho 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 3Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 4
... treatment for Peripheral Artery DiseaseAUSTIN, Texas, Jan. 8 ... is the first hospital in the world to ... to successfully treat chronic total occlusions (CTOs), or ... Heart interventional cardiologist, Frank Zidar, M.D. used the ...
... MEMPHIS, Tenn., Jan. 8 St. Jude Children,s Research,Hospital(R) ... has increased his commitment to Eagles for St. Jude ... St. Jude for every eagle he,cards on the 2009 ... powerful program that,has united Villegas, FedExCup Champion Vijay Singh ...
... to Terrorist Missile StrikesNEW YORK, Jan. 8 ... North America today committed to raise $10 million to ... of a major initiative to support and stand in ... the terrorist organization in control of the Gaza Strip. ...
... Jan. 8 The National eHealth Collaborative, formerly AHIC ... leadership elections in which Kevin Hutchinson, President and CEO ... Chair of the organization,s 2009 Board of Directors. ... Health Information Community (AHIC), a federal advisory committee established ...
... Wyeth (NYSE: WYE ) announced today that ... on Wednesday, January 14, 2009 at 11:30 a.m. Eastern ... President, U.S. and Pharmaceutical Business Units, Wyeth Pharmaceuticals. Wyeth,s ... www.wyeth.com and available for replay following the conference.Wyeth ...
... ColiseumNEW YORK, Jan. 8 Stand Up for a Cure ... a Valentine,s Day show with Barry Manilow , in partnership ... held on February 14th, 2009 at Nassau Coliseum, and tickets for ... or by calling Stand Up for a Cure at 212 209 ...
Cached Medicine News:Health News:Heart Hospital of Austin First in World to Use New Device for Blocked Arteries 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 3Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 4Health News:UJC and Jewish Federations of North America Commit $10 Million for Needs in Southern Israel 2Health News:Kevin Hutchinson Elected Vice Chair of Board of Directors for National eHealth Collaborative 2Health News:Wyeth to Present at the JP Morgan Healthcare Conference 2Health News:Barry Manilow Brings Valentine's and Music to New York With Concert to Raise Funds for Breast Cancer Research 2
(Date:8/27/2015)... DURECT Corporation (Nasdaq: DRRX ) announced ... upcoming healthcare conferences.  , James ... the Rodman & Renshaw Investment Conference on Thursday, September ... being held at the St. Regis Hotel in ... webcast of the presentation will be available by accessing ...
(Date:8/27/2015)... 2015 ieCrowd™ today announced the achievement ... of the company,s supplemental oxygen delivery device, Smart ... developed by ieCrowd,s subsidiary Smart Oxygen Solutions TM ... for oxygen based on level of activity.  The ... the Smart Oxygen device would require a series ...
(Date:8/27/2015)... , Aug. 27, 2015  Eli Lilly and ... Stanley Global Healthcare Conference on Thursday, September 17, 2015. ... president of Lilly Oncology and Richard Gaynor , ... affairs for Lilly Oncology, will participate in a fireside ... A live audio webcast will be available on ...
Breaking Medicine Technology:DURECT to Participate in Upcoming Healthcare Conferences 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 4Lilly to Participate in Morgan Stanley Global Healthcare Conference 2
... advantage of five major benefits of the new health care law, ... To help you better understand the Affordable Care Act, ... , a web portal that explains what,s changing and when. ... is Mayra Alvarez, Director of Public Health Policy in the Office ...
... 2011 Echo Therapeutics, Inc. (OTCBB: ... as a non-invasive, wireless, transdermal continuous glucose monitoring ... transdermal drug delivery, today announced that Christopher P. ... Financial Officer.  Mr. Schnittker is a senior executive ...
Cached Medicine Technology:Five Benefits of the New Health Care Law 2Echo Therapeutics Appoints Christopher P. Schnittker as Chief Financial Officer 2Echo Therapeutics Appoints Christopher P. Schnittker as Chief Financial Officer 3
... The introduction of the AMO ... in Phaco technology; The combination of ... in complete control of fluidic conditions ... as the "smart Pump" orchestrates the ...
... The Catalyst system introduces a ... precision to microsurgical instrumentation. It ... digital design with advanced microcomputer ... simple to operate with a ...
The CV-12000 provides the surgeon with all the options to perform today's newest techniques....
Compact ultrasonic phacoemulsification system....
Medicine Products: